Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-07-13

Clinical Trial Update: Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days [NA]

View source ↗

Summary

This clinical trial evaluated alternate-day ovarian stimulation using recombinant FSH and a GnRH agonist for infertility; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GnRH agonist (gonadotropin-releasing hormone agonist)
  • recombinant FSH (follicle-stimulating hormone)

Snippet

Sponsor: Fertility - Assisted Fertilization Center | Conditions: Infertility | NA | Status: COMPLETED